What happens if I choose no treatment for HER2-Positive Breast Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding the Choice of No Treatment for HER2-Positive Breast Cancer
This is an important question that deserves a thoughtful, evidence-based answer. Let me explain what the medical literature tells us about this decision.
The Clinical Reality of HER2-Positive Breast Cancer
HER2-positive breast cancer is considered an aggressive subtype because the cancer cells have extra copies of the HER2 gene, which makes them grow faster than some other breast cancers. This is actually why effective treatments exist for this type—the HER2 protein is a clear target that doctors can attack with specific medications.
What Happens Without Treatment: The Medical Perspective
For early-stage disease (before spread): Without treatment, HER2-positive breast cancers typically progress more rapidly than hormone-receptor positive cancers. Historical data shows that untreated HER2-positive cancers have higher recurrence rates (cancer returning) compared to treated patients. The specific risk depends on:
- Tumor size
- Lymph node involvement
- Other biomarkers (like Ki-67, which measures how fast cells are dividing)
- Your overall health
For advanced/metastatic disease: Without treatment, HER2-positive metastatic breast cancer generally progresses, meaning the cancer spreads to more organs and grows over time. The timeline varies by individual, but progression typically occurs within months rather than years.
Why Treatment Matters for HER2-Positive Cancer
According to the webinar discussion featuring Dr. [removed] Lopez-Correa, MD, PhD (an oncologist with HER2-positive breast cancer herself), the decision-making around HER2-positive breast cancer involves understanding:
- HER2-targeted therapies work: Medications like trastuzumab (Herceptin) and newer antibody-drug conjugates like trastuzumab deruxtecan (Enhertu) are specifically designed to attack HER2-positive cancer cells
- Treatment combinations are standard: Modern approaches often combine HER2-targeted drugs with chemotherapy or hormone therapy, depending on your specific tumor characteristics
- Individual factors matter: Your doctor considers your age, overall health, other medical conditions, and quality-of-life priorities when recommending treatment
The Quality-of-Life Consideration
An important perspective from the medical community is that treatment decisions should balance:
- Risk management (controlling the cancer)
- Side effect burden (how treatment affects your daily life)
- Your personal values (what matters most to you)
Dr. [removed]-Correa's experience illustrates this—she discussed the real challenges of managing side effects from CDK4/6 inhibitors while also recognizing the importance of treating an aggressive cancer type.
Questions to Ask Your Oncologist
If you're considering no treatment or delaying treatment, these questions are essential:
-
What is my specific stage and prognosis with and without treatment? (Your doctor can give you personalized risk estimates based on your tumor characteristics)
-
What are the treatment options available for my specific HER2-positive cancer? (Early-stage vs. metastatic treatments differ significantly)
-
What is the timeline for disease progression if I don't treat? (This helps you understand the urgency)
-
Are there less intensive treatment options that might fit my quality-of-life goals? (Some patients benefit from sequential or intermittent approaches)
-
How will we monitor my cancer if I choose observation rather than treatment? (Imaging schedules, blood tests, symptom monitoring)
-
Can we revisit this decision if my situation changes? (Treatment decisions aren't always permanent—you can reassess)
Important Context
The choice of no treatment is ultimately yours to make, but it should be an informed choice made in partnership with your oncology team. HER2-positive breast cancer is one of the cancer types where we have the most effective targeted treatments available. Your doctor's role is to help you understand:
- What your specific cancer is likely to do
- What treatment can accomplish
- What the realistic side effects are
- How this fits with your life circumstances and values
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for HER2-Positive Breast Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: